Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M TRISTANI

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
NMR in Biomedicine|December 1, 1989
Metabolic consequences of coronary stenosis. Transmurally heterogeneous myocardial ischemia studied by spatially localized 31P NMR spectroscopyK Uğurbil, H Merkle, P M Robitaille, et al.
American Journal of Medical Genetics. Part A|January 19, 2006
Andersen-Tawil syndrome: prospective cohort analysis and expansion of the phenotypeG Yoon, S Oberoi, M Tristani-Firouzi, et al.
Journal of the American Chemical Society|February 1, 2011
Design, synthesis, and study of a mycobactin-artemisinin conjugate that has selective and potent activity against tuberculosis and malariaMarvin J Miller, Andrew J Walz, Helen Zhu, et al.
Neurology|June 11, 2003
PIP2 binding residues of Kir2.1 are common targets of mutations causing Andersen syndromeM R Donaldson, J L Jensen, M Tristani-Firouzi, et al.
Cell|May 24, 2001
Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndromeN M Plaster, R Tawil, M Tristani-Firouzi, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
NMR in Biomedicine|December 1, 1989
Metabolic consequences of coronary stenosis. Transmurally heterogeneous myocardial ischemia studied by spatially localized 31P NMR spectroscopyK Uğurbil, H Merkle, P M Robitaille, et al.
American Journal of Medical Genetics. Part A|January 19, 2006
Andersen-Tawil syndrome: prospective cohort analysis and expansion of the phenotypeG Yoon, S Oberoi, M Tristani-Firouzi, et al.
Journal of the American Chemical Society|February 1, 2011
Design, synthesis, and study of a mycobactin-artemisinin conjugate that has selective and potent activity against tuberculosis and malariaMarvin J Miller, Andrew J Walz, Helen Zhu, et al.
Neurology|June 11, 2003
PIP2 binding residues of Kir2.1 are common targets of mutations causing Andersen syndromeM R Donaldson, J L Jensen, M Tristani-Firouzi, et al.
Cell|May 24, 2001
Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndromeN M Plaster, R Tawil, M Tristani-Firouzi, et al.
Pageof 3